Quest Diagnostics Incorporated (DGX) News

Quest Diagnostics Incorporated (DGX): $137.18

-1.12 (-0.81%)

POWR Rating

Component Grades













Filter DGX News Items

DGX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

DGX News Highlights

  • DGX's 30 day story count now stands at 34.
  • Over the past 25 days, the trend for DGX's stories per day has been choppy and unclear. It has oscillated between 1 and 12.
  • DOW, PACK and BASE are the most mentioned tickers in articles about DGX.

Latest DGX News From Around the Web

Below are the latest news stories about Quest Diagnostics Inc that investors may wish to consider to help them evaluate DGX as an investment opportunity.

Down 17.9% in 4 Weeks, Here's Why Quest Diagnostics (DGX) Looks Ripe for a Turnaround

Quest Diagnostics (DGX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Yahoo | January 21, 2022

Bridge to Health Connects New Mexico Residents to Local Resources to Help Families Live Healthier Lives

Over 2,200 attend events in Las Cruces and Albuquerque; over 1,100 bags of groceries distributed to families

Yahoo | January 20, 2022

Quest Diagnostics (DGX) Expands Extended Care With New Buyout

This latest acquisition builds on Quest Diagnostics' (DGX) 2018 acquisition of Mobile Medical Examination Service (MedXM), a provider of home-based health risk assessments and related services.

Yahoo | January 19, 2022

Quest Diagnostics Launches Virtual Preventive Care Service Through QuestDirect™ to Help Individuals Take Control of Their Health

Adults across the country can now access comprehensive virtual preventive care without visiting a doctor's office through the new Comprehensive Health Profile from QuestDirect™ the consumer-initiated testing platform from Quest Diagnostics (NYSE: DGX). This new offering evaluates more than 100 health-related data points -- combining access to the same laboratory tests doctors order, a behavioral health risk assessment and biometric measurements, such as weight and blood pressure, to give individ

Yahoo | January 19, 2022

Quest diagnostics acquires Pack Health to improve value-based care in stock and cash deal

Quest Diagnostics (DGX) is acquiring Pack Health in an all-cash equity transaction.Pack Health is a patient-engagement company that helps individuals adopt healthier behaviors to

Seeking Alpha | January 18, 2022

Quest Diagnostics to Acquire Patient-Engagement Company Pack Health to Improve Value-Based Care

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive agreement to acquire Pack Health in an all-cash equity transaction. Pack Health is a patient-engagement company that helps individuals adopt healthier behaviors to improve outcomes.

Yahoo | January 18, 2022

Working to Bridge the Health Equity Gap in Underserved Communities

Quest for Health Equity Leader Ruth Clements Reflects on Key Lessons Learned

Yahoo | January 14, 2022

Jobless Claims Jump More than Expected; Stocks Advance

Digest of today's breaking financial and economic news; jobless claims, stock market gains, and Delta Air Lines news.

Yahoo | January 13, 2022

Quest Diagnostics (DGX) Posts Preliminary Q4 & 2021 Results

Quest Diagnostics (DGX) posts preliminary fourth-quarter and full-year results, reflecting an increase in COVID-19 testing services and a steady recovery in the company's base testing volumes.

Yahoo | January 13, 2022

Will Weakness in Quest Diagnostics Incorporated's (NYSE:DGX) Stock Prove Temporary Given Strong Fundamentals?

With its stock down 9.9% over the past month, it is easy to disregard Quest Diagnostics (NYSE:DGX). But if you pay...

Yahoo | January 13, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5986 seconds.